University Hospital, Basel, Switzerland Clinical Trials
Sponsors / University Hospital, Basel, Switzerland
695 ClinicalTrials.gov entries name University Hospital, Basel, Switzerland as the lead sponsor. Of these, 114 are recruiting, 20 are active without new recruitment, and 502 have completed. The registry records 31 terminated or withdrawn trials for University Hospital, Basel, Switzerland. The most common reasons cited for termination include slow or insufficient recruitment, investigator or site changes. Planned participant enrollment across these trials sums to 528,854. Figures on this page are sourced from ClinicalTrials.gov and refreshed with each registry update.
695
Total Trials
114
Recruiting
20
Other Active
502
Completed
31
Terminated / Withdrawn
528,854
Total Enrollment
Termination reasons: Recruitment61% · Other32% · PI/or_Site3% · Efficacy3%
Recent Terminations
- MEN1 Gene Mutation"The study was prematurely terminated due to significant difficulties in recruiting participants, arising from the extremely rare nature of the targeted gene mutation."
- NCT04323553 Stopped Jan 2025Analysis Transmission Rate"This study is no longer of interested as one of the technology used is already outdated."
- NCT04060160 Stopped Sep 2024Acne Lesions"After careful consideration and review of the data, the study team has determined that it is in the best interest of all parties involved to conclude the study at this juncture."
- Diabetes Mellitus Type 2 in Obese"Too low recruitment in group with patients with diabetes."
- Delirium"insufficient recruitment over a long period"
- Shock"Volume resuscitation procotol has changed around 2017/2018 to less volume/more vasopressors."
- NCT03487484 Stopped Mar 2020Rectal Cancer"insufficient recruitment"
- Autophagy
- Unilateral Simple Inguinal Hernia"USB is responsible party on behalf of the principal investigator (PI). As PI cannot be tracked (lost to follow-up), the USB as sponsor set overall recruitment status unless the PI can be identified or tracked."
- NCT03488654 Stopped Dec 2014Coronary Artery Disease"Recruitement problems as single centre study"
Active Trials (20 total)
- NCT04966299
- NCT06799715
- NCT05471037
- NCT07409012
- NCT07546695
- LSD Reaction NANCT07309471
- NCT06394180
- NCT07297394
- Hepato Cellular Carcinoma (HCC) PHASE2/PHASE3NCT07302919
- NCT07419048
- NCT07444788
- NCT06381934
- NCT07276152
- Hyponatremia NANCT07273630
- NCT07398079
- NCT05595954
- NCT05649384
- NCT05400707
- NCT06978777
- NCT07361263